bcr/abl特异性siRNA真核表达载体的构建及鉴定  

Construction of Eukaryotic Expression Vector of siRNA Specific to bcr/abl Fusion Gene

作　　者：席亚明[1] 刘霆[1] 孟文彤[1] 汪宇辉[2] 顾玲[1] 陆晓茜[1] 龚玉萍[1] 

机构地区：[1]四川大学华西医院血液科,成都610041 [2]四川大学华西基础医学与法医学院生物医学工程实验室

出　　处：《四川大学学报（医学版）》2005年第4期460-463,共4页Journal of Sichuan University(Medical Sciences)

基　　金：国家自然科学基金(批准号30100074)资助

摘　　要：目的构建bcr/abl的特异性siRNA真核细胞表达载体,并初步探索对K562细胞bcr/ablmRNA和P210蛋白的影响。方法根据GenBank数据库提供的bcr/abl基因核苷酸序列,按照Tuschl设计原则,选择设计双链小干扰RNA(smallinterferingRNA,siRNA),再转化为能表达其小发卡结构RNA(smallhairpinRNAs,shRNA)的DNA序列,并与pTER质粒定向连接,构建受控于人RNA聚合酶启动子H1的真核表达载体pTER117、pTER363,经限制性内切酶酶切和DNA测序进行鉴定;在脂质体的介导下转染K562细胞,用RT-PCR分析bcr/ablmRNA的表达,细胞化学染色检测P210蛋白的表达。结果构建bcr/abl融合基因siRNA真核表达载体pTER117、pTER363,经限制性内切酶酶切和DNA测序证实与设计完全一致,转染K562细胞24h后,pTER117、pTER363分别使bcr/ablmRNA的相对水平下降52%、43%,使P210蛋白分别下降47%、40%。结论bcr/abl融合基因siRNA真核细胞表达载体构建成功,并有效干扰K562细胞bcr/abl的表达。Objective To construct eukaryotic expression vector of siRNA specific to bcr/abl and to initially investigate the effect of recombinant plasmid on bcr/abl and P210 protein expression in K562 cells. Methods siRNA(small interfering RNA)was designed according to the Tuschl's principle of RNAi-based medicine, and was converted into cDNA coding expression of shRNA(small hairpin RNAs)of siRNA for bcr/abl fusion gene. The cDNA was synthesized and inserted into plasmid pTER. The pTER117 and pTER363 of recombinant plasmid being eukaryotic expression vector was controlled by the H_1 promoter of RNA polymerase Ⅲ, identified by the restriction map and the sequence analysis, and transfected into K562 cells by Lipofectamine. Expression of bcr/abl mRNA was assayed by RT-PCR; expression of P210 protein was detected by immunohistochemistry. Results The pTER117 and pTER363 of recombinant plasmid identified by the restriction map and the sequence analysis completely coincided with the designs. 24 hours after transfection in K562 cells, the recombinant plasmid could down regulate the expression of the bcr/abl mRNA and bcr/abl protein(P210) in K562 cells. Conclusion The siRNA eukaryotic expression vector against bcr/abl mRNA has been successfully conctructed, and it effectively inhibits the expression of bcr/abl in K562 cells.

关 键 词：慢性髓细胞性白血病 BCR/ABL融合基因 真核表达载体 RNA干扰 K562 

分 类 号：R733.7[医药卫生—肿瘤]